FDA Issues Drug Safety Communication Regarding Use of General Anesthetic and Sedation Drugs in Young Children

Medical Drug Safety

Today, the FDA issued a drug safety communication that it has approved previously announced label changes regarding the use of general anesthetic and sedation medicines in children younger than 3 years. These changes include: A new Warning stating that exposure to these medicines for lengthy periods of time or over multiple surgeries or procedures may...

Read More

Eliquis Blood Thinner Medication Lawsuits for Life-Threatening & Irreversible Bleeds – Litigation Update

Blood Thinner Litigation

Lawsuits have been and continue to be filed by individuals who have suffered various bleed-related injuries (often irreversible and fatal) as a result of taking Eliquis (apixaban), an oral tablet used to reduce the risk of stroke and dangerous blood clots (systemic embolism). Eliquis is manufactured by Bristol-Myers Squibb Company of Princeton, N.J. and marketed...

Read More

Acid Reflux PPI Medication Lawsuits for Kidney Problems Will Proceed But Not As Centralized MDL

Acid Reflux PPI Lawsuits for Kidney Disease & Failure

Recently, individuals who have suffered kidney problems after taking proton pump inhibitors (PPIs), such as Nexium, Prilosec, Prevacid and others, asked to have their lawsuits centralized in the federal Middle District of Louisiana in Baton Rouge.  Specifically, they asked the Judicial Panel on Multidistrict Litigation (JPML) to create a multidistrict litigation (MDL) docket for the cases. A...

Read More